-+ 0.00%
-+ 0.00%
-+ 0.00%

POLYRIZON ANNOUNCES SUCCESSFUL COMPLETION ENROLLMENT OF ALL 120 PATIENTS IN U.S. CLINICAL STUDY OF NASARIX ALLERGY BLOCKER

Reuters·10/27/2026 12:16:00

Please log in to view news